Data Cart

Your data extract

Count Item Type
0 variables
0 samples
View Cart
The DHS Program, which manages registration and access for IPUMS DHS, is again reviewing new user applications and requests for expanded access from currently approved users.

MLPREANMAL

(MLPREANMAL)
Way to avoid getting malaria: Take antimalarial drug

Codes and Frequencies

Display

Can't find the category you are looking for? Try the Detailed codes

Description

MLPREANMAL indicates whether, in response to an open-ended question, the woman reported taking antimalarial drugs as a way malaria can be avoided.

Comparability — Index

Comparability

Apart from universe differences and slight differences in question wording (described below), MLPREANMAL is comparable across samples.

Comparability - Standard DHS

Prior to Phase 8, MLPREANMAL is a country-specific variable not included in the standard DHS questionnaire. In Phase 8, this variable has the standard name ML503D.

Comparability — Guinea [top]

The 1999 Guinea survey includes "Take nivaquine/chloroquine" as a response category. Nivaquine and chloroquine are both antimalarial drugs.

Universe

  • Burkina Faso 2021: All women age 15-49.
  • Ghana 2022: All women age 15-49.
  • Guinea 1999: Women age 15-49 who know malaria can be prevented.
  • Madagascar 2021: All women age 15-49.
  • Mali 2018: All women age 15-49.
  • Rwanda 2000: All women age 15-49.
  • Rwanda 2005: All women age 15-49.
  • Tanzania 2022: Women age 15-49 in households selected for the men's survey.
  • Burkina Faso: 2021-W, 2021-C, 2021-B
  • Ghana: 2022-W, 2022-C, 2022-B
  • Guinea: 1999-W, 1999-C, 1999-B
  • Madagascar: 2021-B, 2021-C, 2021-W
  • Mali: 2018-W, 2018-C, 2018-B, 2018-W
  • Rwanda: 2000-W, 2000-W, 2000-C, 2000-B, 2005-W, 2005-W, 2005-B, 2005-C
  • Tanzania: 2022-W, 2022-C, 2022-B